D-Index & Metrics Best Publications
Punnee Pitisuttithum

Punnee Pitisuttithum

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 50 Citations 19,309 187 World Ranking 3257 National Ranking 4

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Acquired immunodeficiency syndrome

His primary areas of study are Immunology, Virology, Vaccine efficacy, AIDSVAX and Antibody. His Immunology study is mostly concerned with Vaccination, Vaccine trial, Immunogenicity, Immunity and Malaria. He works mostly in the field of Vaccination, limiting it down to topics relating to Internal medicine and, in certain cases, Acquired immunodeficiency syndrome, as a part of the same area of interest.

His study in Virology is interdisciplinary in nature, drawing from both Epitope, Monoclonal antibody and Immune system. His Vaccine efficacy research focuses on subjects like Antigen, which are linked to HIV Antigens. His AIDSVAX study integrates concerns from other disciplines, such as Regimen and Peptide sequence.

His most cited work include:

  • Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand (2488 citations)
  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial (1399 citations)
  • A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women (776 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Internal medicine, Virology, Antibody and Vaccination. As a part of the same scientific family, Punnee Pitisuttithum mostly works in the field of Immunology, focusing on HIV vaccine and, on occasion, Family medicine. His Internal medicine study combines topics in areas such as Surgery and Acquired immunodeficiency syndrome.

Punnee Pitisuttithum works mostly in the field of Virology, limiting it down to concerns involving AIDSVAX and, occasionally, Placebo. Punnee Pitisuttithum regularly links together related areas like Antigen in his Antibody studies. His studies deal with areas such as Young adult, Titer, Randomized controlled trial, Subclass and Reactogenicity as well as Vaccination.

He most often published in these fields:

  • Immunology (43.94%)
  • Internal medicine (32.32%)
  • Virology (29.29%)

What were the highlights of his more recent work (between 2015-2021)?

  • Immunology (43.94%)
  • Antibody (28.79%)
  • Vaccination (23.74%)

In recent papers he was focusing on the following fields of study:

Punnee Pitisuttithum mostly deals with Immunology, Antibody, Vaccination, Internal medicine and HIV vaccine. His work on Odds ratio expands to the thematically related Immunology. His studies deal with areas such as AIDSVAX, Immunity and Virology as well as Antibody.

His study on Live attenuated influenza vaccine is often connected to H5N1 vaccine as part of broader study in Vaccination. Punnee Pitisuttithum combines subjects such as Seroconversion and Immunogenicity with his study of Internal medicine. The concepts of his HIV vaccine study are interwoven with issues in Epitope, Canarypox, Herpes simplex virus and Vaccine efficacy.

Between 2015 and 2021, his most popular works were:

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) (140 citations)
  • V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144. (35 citations)
  • Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial. (32 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Acquired immunodeficiency syndrome

Punnee Pitisuttithum spends much of his time researching Immunology, Antibody, Vaccination, Virology and HIV vaccine. His AIDSVAX research extends to the thematically linked field of Immunology. The Vaccination study combines topics in areas such as Placebo, Internal medicine and Immunogenicity.

His studies in Internal medicine integrate themes in fields like Booster dose, Seroconversion, Tetanus and Diphtheria. His research investigates the link between Virology and topics such as Antibody-dependent cell-mediated cytotoxicity that cross with problems in Cold sore, Mucosal immunology, Ex vivo, Isotype and Immunoglobulin class switching. His HIV vaccine research includes themes of Antigenicity, Antigen, Antigenic Diversity, Immunogen and Computational biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal.
The New England Journal of Medicine (2009)

3498 Citations

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)

1918 Citations

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

Elmar A. Joura;Anna R. Giuliano;Ole-Erik Iversen;Celine Bouchard.
The New England Journal of Medicine (2015)

1325 Citations

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

Maria Rosario Capeding;Ngoc Huu Tran;Sri Rezeki S. Harun Hadinegoro;Hussain Imam Hj Muhammad Ismail.
The Lancet (2014)

1016 Citations

Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand

Punnee Pitisuttithum;Peter Gilbert;Marc Gurwith;William Heyward.
The Journal of Infectious Diseases (2006)

962 Citations

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Melissa D. Simek;Wasima Rida;Frances H. Priddy;Pham Pung.
Journal of Virology (2009)

773 Citations

Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2

Arjen M Dondorp;Varunee Desakorn;Wirichada Pongtavornpinyo;Duangjai Sahassananda.
PLOS Medicine (2005)

486 Citations

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert.
Journal of Virology (2012)

427 Citations

Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp.
Science Translational Medicine (2014)

426 Citations

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan.
Immunity (2013)

406 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Punnee Pitisuttithum

David C. Montefiori

David C. Montefiori

Duke University

Publications: 279

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 196

Georgia D. Tomaras

Georgia D. Tomaras

Duke University

Publications: 185

Dan H. Barouch

Dan H. Barouch

Harvard Medical School

Publications: 141

Peter B. Gilbert

Peter B. Gilbert

Fred Hutchinson Cancer Research Center

Publications: 138

Michael S. Seaman

Michael S. Seaman

Beth Israel Deaconess Medical Center

Publications: 120

Stephen J. Kent

Stephen J. Kent

University of Melbourne

Publications: 117

Guido Ferrari

Guido Ferrari

Duke University

Publications: 115

Dennis R. Burton

Dennis R. Burton

Scripps Research Institute

Publications: 115

M. Juliana McElrath

M. Juliana McElrath

University of Washington

Publications: 109

John R. Mascola

John R. Mascola

National Institute of Allergy and Infectious Diseases

Publications: 105

Celia C. LaBranche

Celia C. LaBranche

Duke University

Publications: 103

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 102

Galit Alter

Galit Alter

MIT

Publications: 96

Hua-Xin Liao

Hua-Xin Liao

Jinan University

Publications: 90

Merlin L. Robb

Merlin L. Robb

Walter Reed Army Institute of Research

Publications: 87

Trending Scientists

Jeffrey K. Liker

Jeffrey K. Liker

University of Michigan–Ann Arbor

Kuo-En Chang

Kuo-En Chang

National Taiwan Normal University

Alessandro Ferrero

Alessandro Ferrero

Polytechnic University of Milan

Xiaofeng Cao

Xiaofeng Cao

Chinese Academy of Sciences

David L. Harmon

David L. Harmon

University of Kentucky

Guillaume Besnard

Guillaume Besnard

Paul Sabatier University

John M. Nicholls

John M. Nicholls

University of Hong Kong

Jean-Louis Mugnier

Jean-Louis Mugnier

Université Savoie Mont Blanc

Pham Hung Viet

Pham Hung Viet

Vietnam National University, Hanoi

Joel R. Norris

Joel R. Norris

University of California, San Diego

David H. Uttal

David H. Uttal

Northwestern University

Clay F. Semenkovich

Clay F. Semenkovich

Washington University in St. Louis

Alan C. Swann

Alan C. Swann

The University of Texas Health Science Center at Houston

Chen-Lin C. Kulik

Chen-Lin C. Kulik

University of Michigan–Ann Arbor

Mary Ann Glynn

Mary Ann Glynn

Boston College

Something went wrong. Please try again later.